The main benefit of T-DM1 is its ability to target cancer cells specifically, which means fewer side effects compared to conventional chemotherapy. Furthermore, studies have shown that T-DM1 can significantly improve progression-free survival and overall survival in patients with HER2-positive breast cancer.